Detection and Biopsy Guidance of Nasopharyngeal Carcinoma Based on Artificial Intelligence and Endoscopic Images

Launched by CHINESE ACADEMY OF SCIENCES · Jan 9, 2022

Keywords

ClinConnect Summary

This clinical trial is studying a new tool that uses artificial intelligence (AI) to help doctors find and diagnose nasopharyngeal carcinoma, which is a type of cancer located in the back of the throat. The goal is to improve the accuracy of biopsies—tests that involve taking a small sample of tissue to check for cancer—especially since this area can be difficult to see and assess. By using AI alongside endoscopic images (pictures taken with a special camera), the researchers hope to make the biopsy process more effective and reduce the chances of missing a diagnosis.

To participate in this study, you would need to have a lesion (an abnormal area) in your nasopharynx that doctors think needs a biopsy. The trial is open to individuals aged 65 to 74, regardless of gender, but it is not suitable for anyone who has already been treated for nasopharyngeal cancer or other related cancers. If you choose to take part, you can expect to undergo an endoscopy, where a doctor will look at the area, and the AI tool will assist them in guiding the biopsy to improve the chances of identifying any issues accurately. This trial is currently recruiting participants, and the findings could help enhance how nasopharyngeal cancer is diagnosed in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • The patient was found to have a nasopharyngeal lesion through the nasopharyngeal endoscopy and the clinicans considered it necessary to perform an biopsy.
• • Hemilateral lesion with limited size.
• Exclusion Criteria:
• • Patients with nasopharyngeal cancer, oropharyngeal cancer, hypopharyngeal cancer, etc. who have already been treated.